Inventor · disambiguated record

Brendan Quinn

Also filed as: QUINN BRENDAN

23 granted patents·34 pending applications·487 citations·filing 2021–2025

97Inventor score

Technology areasC12N A61K C07K A61P C12Y

Files withDYNE THERAPEUTICS INC56 DYNE THERAPEUTICS LNC1

Top patents by PatentIndex Score

57 records

0199US12329824B1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Jun 17, 2025·4 cites·30 claims
0299US12239717B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Mar 4, 2025·13 cites·30 claims
0399US12239716B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Mar 4, 2025·13 cites·30 claims
0499US12144867B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Nov 19, 2024·14 cites·19 claims
0599US12144868B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Nov 19, 2024·14 cites·19 claims
0699US12102687B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Oct 1, 2024·17 cites·30 claims
0799US11986537B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2023·Granted May 21, 2024·24 cites·19 claims
0899US11969475B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Apr 30, 2024·25 cites·30 claims
0999US11844843B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Dec 19, 2023·30 cites·30 claims
1099US11839660B2Anti-transferrin receptor antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2023·Granted Dec 12, 2023·30 cites·16 claims
1199US11771776B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Granted Oct 3, 2023·32 cites·19 claims
1299US11759525B1Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Sep 19, 2023·32 cites·22 claims
1399US11679161B2Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Jun 20, 2023·38 cites·25 claims
1499US11672872B2Anti-transferrin receptor antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2022·Granted Jun 13, 2023·37 cites·21 claims
1599US11648318B2Anti-transferrin receptor (TFR) antibody and uses thereofDYNE THERAPEUTICS INC·Filed 2022·Granted May 16, 2023·37 cites·9 claims
1699US11638761B2Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted May 2, 2023·47 cites·24 claims
1799US11633498B2Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2022·Granted Apr 25, 2023·37 cites·30 claims
1897US11931421B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Granted Mar 19, 2024·26 cites·7 claims
1995US12128109B2Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2023·Granted Oct 29, 2024·17 cites·28 claims
2092US2025360223A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2190US12440574B2Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2024·Granted Oct 14, 2025·0 cites·22 claims
2290US12403203B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Granted Sep 2, 2025·0 cites·19 claims
2388US2025367310A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
2486US12440575B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Oct 14, 2025·0 cites·30 claims
2584US2025339553A1Muscle targeting complexes and formulations for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
2680US12397062B2Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2025·Granted Aug 26, 2025·0 cites·30 claims
2771US2025057972A1Muscle targeting complexes and formulations for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
2865US2024382513A1Muscle targeting complexes and uses thereof for modulation of genes associated with muscle healthDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
2965US2023203180A1Muscle targeting complexes and uses thereof for modulation of genes associated with muscle healthDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3065US2025249117A1Dosing of muscle targeting complexes for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3164US2024318177A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3264US2024382609A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3364US2025099603A9Muscle targeting complexes and uses thereof for treating friedreich's ataxiaDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3464US2024318176A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3564US2025249116A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
3664US2024209119A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3764US2025025570A1Muscle targeting complexes for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3864US2024368296A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
3964US2024294921A1Muscle targeting complexes and uses thereof for treating pompe diseaseDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4061US2023285586A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4161US2024117356A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4260US2025018050A1Dosing of muscle targeting complexes for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4359US2023144436A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4459US2024325558A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
4559US2024110184A1Muscle targeting complexes and uses thereof for treating facioscapulohumeral muscular dystrophyDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4658US2024016952A1Muscle targeting complexes and uses thereof for treating myotonic dystrophyDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4758US2023287108A1Muscle-targeting complexes and uses thereofDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4858US2023346966A1Muscle-targeting complexes and uses thereof in treating muscle atrophyDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
4956US2023111212A1Muscle targeting complexes and uses thereof for treating dystrophinopathiesDYNE THERAPEUTICS INC·Filed 2021·Application pending·0 cites
5056US2023256112A1Anti-transferrin receptor (tfr) antibody and uses thereofDYNE THERAPEUTICS LNC·Filed 2021·Application pending·0 cites

Showing the top 50 of 57 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Brendan Quinn files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →